What Researchers Did
Researchers conducted a literature review to examine the role and physiological effects of hyperbaric oxygen therapy (HBOT) in wound healing, particularly for compromised skin grafts and flaps.
What They Found
The review confirmed the efficacy of hyperbaric oxygen therapy (HBOT) as an adjunctive treatment for nonhealing wounds and compromised skin grafts and flaps. HBOT offers physiological benefits by reversing wound hypoxia and hypoperfusion, improving healing potential when standard therapies are insufficient.
What This Means for Canadian Patients
Canadian patients with nonhealing wounds or compromised skin grafts and flaps that do not respond to standard care may benefit from hyperbaric oxygen therapy as an additional treatment option. This therapy could help improve tissue oxygenation and perfusion, potentially leading to better healing outcomes and reduced complications.
Canadian Relevance
This study has no direct Canadian connection as it is a general review of hyperbaric oxygen therapy.
Study Limitations
As a literature review, this article synthesizes existing data without presenting new primary research or quantitative outcomes from a specific study.